Curis, Inc. (CRIS) vs FibroBiologics, Inc. Common Stock (FBLG)

A side-by-side comparison of Curis, Inc. and FibroBiologics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Curis, Inc. logo
CRIS
Curis, Inc.
$1M
$0.73HealthcareDelayed quote: Oct 6, 2026, 1:58 PM EDT
FibroBiologics, Inc. Common Stock logo
FBLG
FibroBiologics, Inc. Common Stock
$3M
$1.20HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT

Total return — CRIS vs FBLG

growth of $100 · dividends reinvested · last 3y
CRIS -99.6% (-84.4%/yr)FBLG -99.8% (-87.3%/yr)CRIS compounded faster over this window
050100150Start $10020252026$0$0
CRIS FBLG

CRIS vs FBLG: by the numbers

  • •FBLG is the larger company ($3M vs $1M market cap).
  • •Both run net losses; FBLG's is the smaller (0.00% vs -490.33% net margin).

Metrics side by side

Valuation

MetricCRISFBLG
P/S ratio0.33N/A
P/B ratio0.300.54

Profitability

MetricCRISFBLG
Gross margin99.28%0.00%
Operating margin-348.43%0.00%
Net margin-490.33%0.00%
ROE-450.54%-391.26%
ROIC-567.17%-286.46%

Growth (annualized)

MetricCRISFBLG
Revenue CAGR (5Y)-15.88%N/A
Total return CAGR (5Y)-81.06%N/A

Go deeper

Full CRIS analysisFull FBLG analysisInteractive comparison tool

Dig into the metrics

Curis ROEFibroBiologics, Inc. Common Stock ROECuris operating marginFibroBiologics, Inc. Common Stock operating marginCuris revenue growthFibroBiologics, Inc. Common Stock revenue growthCuris free cash flowFibroBiologics, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.